Continental Chronicles2 years ago
“Concerning the residual plasmid DNA in the drug substance, provide data/information characterizing [...] the size distribution of the residual DNA fragments [and] residual intact circular plasmid,” says a request for clarification Health Canada issued to Pfizer on Aug. 4, 2023. #healthcanada #pfizer #dna #news
    “Concerning the residual plasmid DNA in the drug substance,… | Continental Chronicles | Gan Jing World